首页 > 市场调查报告书 > 医疗设备

医学影像诊断 CT/MRI/X光

市场调查报告书

商品编码

1741513

全球放射性示踪剂市场按类型、应用、最终用户和地区划分

Radioactive Tracer Market, By Type, By Application, By End User, By Geography

出版日期: 2025年03月27日 | 出版商:

Coherent Market Insights | 英文 140 Pages | 商品交期: 2-3个工作天内

价格

简介目录

预计 2025 年全球放射性示踪剂市场规模为 37.2 亿美元，到 2032 年将达到 60.5 亿美元，2025 年至 2032 年的年复合成长率（CAGR）为 7.2%。

报告范围		报告详细信息
基准年	2024	2025年的市场规模	37.2亿美元
效能数据	2020-2024	预测期	2025-2032
预测期：2025-2032年复合年增长率：	7.20%	2032年价值预测	60.5亿美元

放射性示踪剂已成为医疗保健、研究和石油探勘等各行各业的必备工具。这些示踪剂由放射性物质组成，这些物质会发出易于检测和测量的辐射。示踪剂用于追踪特定分子的运动，研究各种生物过程，并识别地下蕴藏物的潜在来源。近年来，由于放射性示踪剂在医疗诊断和治疗以及环境和石化领域的应用不断扩大，全球放射性追踪剂市场经历了显着增长。

市场动态：

放射性示踪剂市场受到多种因素的推动，包括技术进步、慢性病的增加、个人化医疗需求的增加等。由于正子断层扫描 (PET) 和单光子发射电脑断层扫描 (SPECT) 等诊断影像技术的日益普及，该市场正在经历显着增长，这些技术利用放射性示踪剂来检测和分析各种疾病和状况。

另一方面，挑战包括与放射性物质使用和处置相关的严格法规。监管机构制定了严格的指导方针，以确保放射性示踪剂的安全处理和处置，这显着增加了生产成本，从而影响了市场成长。此外，熟练专业人员的匮乏以及核医程序的高昂费用预计也会在一定程度上抑制市场成长。

儘管面临这些挑战，放射性示踪剂市场仍充满成长机会。放射性药物製造技术的进步和新型放射性同位素的开发有望为市场参与者开闢新的发展途径。此外，石油和天然气探勘、环境监测和工业检测等行业对放射性示踪剂的日益普及也有望进一步推动市场成长。

本研究的主要特点

本报告对全球放射性示踪剂市场进行了详细分析，并提供了预测期 2025-2032（以 2024 年为基准年）的市场规模和复合年增长率。
它还揭示了各个领域的潜在商机，并解释了该市场的有吸引力的投资提案矩阵。
它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景和主要企业采用的竞争策略的主要考察。
全球放射性示踪剂市场的主要企业是根据公司亮点、产品系列、关键亮点、财务绩效和策略等参数进行的分析。
本报告的见解将使负责人和公司经营团队能够就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
全球放射性示踪剂市场报告迎合了该行业的各个相关人员，包括投资者、供应商、产品製造商、经销商、新进入者和金融分析师。
相关人员可以透过用于分析全球放射性示踪剂市场的各种策略矩阵来更轻鬆地做出决策。

PerkinElmer Inc.
Cardinal Health
Bracco
NTP Radioisotopes
Nordion（Canada）Inc.
Curium
IRE
Telix Pharmaceuticals Limited
NorthStar Medical Radioisotopes, LLC
Lantheus Holdings, Inc.
Eckert & Ziegler
Siemens Healthineers
GE Healthcare
Mallinckrodt Nuclear Medicine LLC
Jubilant DraxImage Inc.
Sumitomo Heavy Industries, Ltd.

第 10 章章节

调查方法
关于出版商

简介目录

Product Code: CMI6389

Radioactive Tracer Market is estimated to be valued at USD 3.72 Bn in 2025 and is expected to reach USD 6.05 Bn by 2032, growing at a compound annual growth rate (CAGR) of 7.2% from 2025 to 2032.

Report Coverage		Report Details
Base Year:	2024	Market Size in 2025:	USD 3.72 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	7.20%	2032 Value Projection:	USD 6.05 Bn

Radioactive tracers have become an essential tool in several industries, including healthcare, research, and oil exploration. These tracers consist of radioactive substances that emit radiation, which can be easily detected and measured. They are used to track the movement of specific molecules, study various biological processes, and identify potential sources of underground reserves. The global radioactive tracer market has witnessed significant growth in recent years, owing to the increasing applications of radioactive tracers in medical diagnostics and treatment, as well as in the environmental and petrochemical sectors.

Market Dynamics:

The radioactive tracer market is driven by several factors, including technological advancements, increasing prevalence of chronic diseases, and the growing demand for personalized medicine. The market is witnessing significant growth due to the rising adoption of diagnostic imaging techniques, such as positron emission tomography (PET) and single-photon emission computed tomography (SPECT), which utilize radioactive tracers to detect and analyze various diseases and conditions.

On the other hand, the market faces certain challenges, such as stringent regulations related to the use and disposal of radioactive substances. Regulatory bodies impose strict guidelines to ensure the safe handling and disposal of radioactive tracers, which significantly increases the cost of production and affects market growth. Additionally, the limited availability of skilled professionals and the high cost associated with nuclear medicine procedures are expected to restrain market growth to some extent.

Despite these challenges, the radioactive tracer market is filled with opportunities for growth. Advancements in radiopharmaceutical manufacturing techniques and the development of new radioactive isotopes are expected to create new avenues for market players. Moreover, the increasing adoption of radioactive tracers in industries such as oil and gas exploration, environmental monitoring, and industrial testing is anticipated to drive market growth further.

Key features of the study:

This report provides in-depth analysis of the global radioactive tracer market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global radioactive tracer market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include PerkinElmer, Cardinal Health, Lantheus Medical Imaging, Bracco Imaging, NTP Radioisotopes, JSC Isotope, ANSTO, Nordion, Curium Pharma, and IRE
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global radioactive tracer market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global radioactive tracer market

Detailed Segmentation:

By Type
- Diagnostic Radioactive Tracers
- Therapeutic Radioactive Tracers
- Others
By Application
- Oncology
- Cardiology
- Neurology
- Thyroid
- Lymphoma
- Endocrinology
- Others
By End User
- Hospitals
- Diagnostic Centers
- Cancer Research Institutes
- Others
By Geography
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Company Profiles
- PerkinElmer
- Cardinal Health
- Lantheus Medical Imaging
- Bracco Imaging
- NTP Radioisotopes
- JSC Isotope
- ANSTO
- Nordion
- Curium Pharma
- IRE

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market, Radioactive Tracer, By Type
- Market Radioactive Tracer, By Application
- Market Radioactive Tracer, By End User
- Market Radioactive Tracer, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Increasing prevalence of chronic diseases
- Short half-life of radiopharmaceuticals
- Emerging applications in oncology
Impact Analysis
Key Highlights
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario

4. Global Radioactive Tracer Market - Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact

5. Global Radioactive Tracer Market, By Type, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Diagnostic Radioactive Tracers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Therapeutic Radioactive Tracers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)

6. Global Radioactive Tracer Market, By Application, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Oncology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Cardiology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Neurology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Thyroid
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Orthopedic
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Endocrinology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)

7. Global Radioactive Tracer Market, By End User, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Specialty Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Diagnostic Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Academic & Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Others
- Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)

8. Global Radioactive Tracer Market, By Region, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, By Country, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Country 2021 -2032
- Country Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
  - U.S.
  - Canada
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,( US$ Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020-2032, (US$ Bn)
  - South Africa
  - North Africa
  - Central Africa

9. Competitive Landscape

PerkinElmer Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Cardinal Health
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Bracco
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
NTP Radioisotopes
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Nordion (Canada) Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Curium
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
IRE
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Telix Pharmaceuticals Limited
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
NorthStar Medical Radioisotopes, LLC
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Lantheus Holdings, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Eckert & Ziegler
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Siemens Healthineers
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
GE Healthcare
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Mallinckrodt Nuclear Medicine LLC
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Jubilant DraxImage Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Sumitomo Heavy Industries, Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Analyst Views

10. Section

Research Methodology
About us

02-2729-4219

+886-2-2729-4219

License/价格

全球放射性示踪剂市场按类型、应用、最终用户和地区划分